GL1X · GenesisL1 explorer

Research workbench

Human dihydroorotate dehydrogenase complexed with brequinar analog

Analyse Human dihydroorotate dehydrogenase complexed with brequinar analog in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1D3G
Type
protein
Length
360 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Dihydroorotate dehydrogenase
EC
1.3.3.1
UniProt
Q02127
Ligands
BRE, FMN, ORO, DDQ, SO4
Pockets
5 · best druggability 0.84

Structure

x-ray diffraction · 1 distinct chain · 46% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ADihydroorotate dehydrogenase (EC 1.3.3.1)protein36046% helix, 16% strandQ02127

Ligands and binding sites

  • BRE · 2-biphenyl-4-yl-6-fluoro-3-methyl-quinoline-4-carboxylic acid · ligand · chains A
  • FMN · Flavin mononucleotide · ligand · chains A
  • ORO · Orotic acid · ligand · chains A
  • DDQ · Decylamine-N,N-dimethyl-N-oxide · ligand · chains A
  • SO4 · Sulfate ion · ion · chains A
  • ACT · Acetate ion · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14550.840.9166BRE, FMN, ORO, DDQ
21010.450.7919empty
31180.410.7621empty
4840.410.7918empty
5820.340.7523empty

Compared structures

  • 1D3G · Human dihydroorotate dehydrogenase complexed with brequinar analog · the same entry in another collection · chain A against A, TM-score 1.00
  • Q02127 · AlphaFold monomer V2.0 prediction for dihydroorotate dehydrogenase (quinone)… · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.